Celularity Inc. (CELU)

Celularity Revenue

Celularity had revenue of $5.43M in the quarter ending June 30, 2026, a decrease of -5.30%. This brings the company's total for the last twelve months to $18.67M, down -58.14% year-over-year. In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. That makes Celularity the 34,197th largest company in the world by revenue and 4,490th in the United States.

• Revenue (ttm): $18.67M
• Revenue Growth: -58.14%
• P/S Ratio: 1.48
• Revenue / Employee: $162,313
• Employees: 115
• Market Cap: 27.56M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Degenerative Disease 17.31M 65.2%
• Biobanking 5.43M 20.5%
• Cell Therapy 3.81M 14.3%

Fiscal year ended Dec 31, 2025 See the full Celularity breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.55M	-27.67M	-51.03%
Dec 31, 2024	54.22M	31.45M	138.11%
Dec 31, 2023	22.77M	4.80M	26.68%
Dec 31, 2022	17.98M	-3.36M	-15.75%
Dec 31, 2021	21.34M	7.06M	49.43%
Dec 31, 2020	14.28M	-	-
Dec 31, 2019	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 20, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error